Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2012

Mar 21, 2012

29777_dirs_2012-03-21_fa9a7c46-e7ac-432b-8433-d51009ae6932.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-03-19

Reporting Person: FULLER H LAURANCE (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-19 Common shares without par value M 5211 $50.6506 Acquired 24814 Direct
2012-03-19 Common shares without par value M 7374 $37.4229 Acquired 32188 Direct
2012-03-19 Common shares without par value M 6699 $41.20 Acquired 38887 Direct
2012-03-19 Common shares without par value S 10800 $60.30 Disposed 28087 Direct
2012-03-19 Common shares without par value S 100 $60.3003 Disposed 27987 Direct
2012-03-19 Common shares without par value S 5055 $60.301 Disposed 22932 Direct
2012-03-19 Common shares without par value S 1229 $60.31 Disposed 21703 Direct
2012-03-19 Common shares without par value S 2100 $60.32 Disposed 19603 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-03-19 Option (right to buy) $50.6506 M 5211 Disposed 2012-04-25 Common shares (5211) Direct
2012-03-19 Option (right to buy) $37.4229 M 7374 Disposed 2013-04-24 Common shares (7374) Direct
2012-03-19 Option (right to buy) $41.20 M 6699 Disposed 2014-04-22 Common shares (6699) Direct

Footnotes

F1: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.